Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

PA Archive/Press Association Images
Major study

Taking ibuprofen can raise the risk of heart failure, scientists warn

Medics used data taken from 10 million patients across Europe.

A COMMON PAINKILLER bought over the counter in pharmacies can raise your risk of heart failure, a new study has claimed.

Ibuprofen, which is used to reduce fever and treat pain or inflammation, is found in many medications.

However, a decade-long study carried out across a number of countries found that those who had taken ibuprofen face an increase in the risk of heart failure by 18% for 14 days after swallowing.

Risk

A team of researchers led by Giovanni Corrao at the University of Milano-Bicocca combed through medical records of nearly 10 million users in four European countries: Germany, Britain, the Netherlands and Italy.

They identified 92,163 hospital admissions for heart failure and then checked to see which of 27 drugs, and at what doses each person admitted was taking.

Overall, they found that current use of non-steroid anti inflammatory drugs (NCAIDS) slightly raised the risk of hospital admission compared to past use for nine drugs.

At very high doses, some doubled the risk of hospital admission.

Two Danish heart experts, Gunnar Gislason and Christian Torp-Pedersen, wrote in the British Medical Journal:

Even a small increase in cardiovascular risk is a concern for public health.

For one drug in particular – diclofenac – the European Society of Cardiology has recommended against its use at any dose, they noted.

Helen Williams, a consultant pharmacist for cardiovascular disease at the Royal Pharmaceutical Society in Britain, noted that the country’s National Health Service had been “moving away” from the powerful drugs in recent years.

‘The sector is in real crisis’: New report reveals the cost of providing childcare >

Poisonous sea creatures spotted on several beaches along the west coast >

Your Voice
Readers Comments
14
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.